Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Levin

Showing results (931-940 of 1,225) with videos related to

Pageof 123
Sort By:
Science (New York, N.Y.)|September 11, 1998
Design of organic molecules with large two-photon absorption cross sectionsM Albota, D Beljonne, J L Brédas, et al.
Nature Neuroscience|March 17, 2026
Restoring rapid natural bimanual typing with a neuroprosthesis after paralysisJustin J Jude, Hadar Levi-Aharoni, Alexander J Acosta, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 29, 2021
X-linked creatine transporter deficiency results in prolonged QTc and increased sudden death risk in humans and disease modelMark D Levin, Simona Bianconi, Andrew Smith, et al.
Epigenetics|December 7, 2018
Cannabinoid exposure and altered DNA methylation in rat and human spermSusan K Murphy, Nilda Itchon-Ramos, Zachary Visco, et al.
Neurotoxicology|August 4, 2009
Genetic aspects of behavioral neurotoxicologyEdward D Levin, Michael Aschner, Ulrike Heberlein, et al.
Breast Cancer Research and Treatment|January 4, 2021
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?N I Bouwer, T G Steenbruggen, J van Rosmalen, et al.
British Journal of Cancer|November 3, 2005
Circadian function in patients with advanced non-small-cell lung cancerR D Levin, M A Daehler, J F Grutsch, et al.
Nature Immunology|November 9, 2010
A role for IL-27p28 as an antagonist of gp130-mediated signalingJason S Stumhofer, Elia D Tait, William J Quinn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 29, 2020
Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric diseaseJonathan A Hollander, Deborah A Cory-Slechta, Felice N Jacka, et al.
Nature Communications|April 5, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunityMark F Maurer, Katherine E Lewis, Joseph L Kuijper, et al.
Pageof 123

Showing results (931-940 of 1,225) with videos related to

Sort By:
Pageof 123
Science (New York, N.Y.)|September 11, 1998
Design of organic molecules with large two-photon absorption cross sectionsM Albota, D Beljonne, J L Brédas, et al.
Nature Neuroscience|March 17, 2026
Restoring rapid natural bimanual typing with a neuroprosthesis after paralysisJustin J Jude, Hadar Levi-Aharoni, Alexander J Acosta, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 29, 2021
X-linked creatine transporter deficiency results in prolonged QTc and increased sudden death risk in humans and disease modelMark D Levin, Simona Bianconi, Andrew Smith, et al.
Epigenetics|December 7, 2018
Cannabinoid exposure and altered DNA methylation in rat and human spermSusan K Murphy, Nilda Itchon-Ramos, Zachary Visco, et al.
Neurotoxicology|August 4, 2009
Genetic aspects of behavioral neurotoxicologyEdward D Levin, Michael Aschner, Ulrike Heberlein, et al.
Breast Cancer Research and Treatment|January 4, 2021
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?N I Bouwer, T G Steenbruggen, J van Rosmalen, et al.
British Journal of Cancer|November 3, 2005
Circadian function in patients with advanced non-small-cell lung cancerR D Levin, M A Daehler, J F Grutsch, et al.
Nature Immunology|November 9, 2010
A role for IL-27p28 as an antagonist of gp130-mediated signalingJason S Stumhofer, Elia D Tait, William J Quinn, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 29, 2020
Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric diseaseJonathan A Hollander, Deborah A Cory-Slechta, Felice N Jacka, et al.
Nature Communications|April 5, 2022
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunityMark F Maurer, Katherine E Lewis, Joseph L Kuijper, et al.
Pageof 123